ALPHA(2)-AUTORECEPTORS AND ALPHA(2)-HETERORECEPTORS MODULATING TYROSINE AND TRYPTOPHAN-HYDROXYLASE ACTIVITY IN THE RAT-BRAIN IN-VIVO - AN INVESTIGATION INTO THE ALPHA(2)-ADRENOCEPTOR SUBTYPES
S. Esteban et al., ALPHA(2)-AUTORECEPTORS AND ALPHA(2)-HETERORECEPTORS MODULATING TYROSINE AND TRYPTOPHAN-HYDROXYLASE ACTIVITY IN THE RAT-BRAIN IN-VIVO - AN INVESTIGATION INTO THE ALPHA(2)-ADRENOCEPTOR SUBTYPES, Naunyn-Schmiedeberg's archives of pharmacology, 353(4), 1996, pp. 391-399
The subtype determination of auto- and hetero-alpha(2)-adrenoceptors m
odulating the synthesis of noradrenaline (NA) and serotonin (5-HT), re
spectively, was assessed using the accumulation of 3,4-dihydroxyphenyl
alanine (dopa) and 5-hydroxytryptophan (5-HTP) after decarboxylase inh
ibition as a measure of the rate of tyrosine and tryptophan hydroxylat
ion in the rat brain in vivo. In the cerebral cortex and hippocampus,
Org 3770 (non-selective alpha(2)-adrenoceptor antagonist, 0.5-10 mg/kg
, i.p.) increased (43%-58%) and clonidine (non-selective alpha(2)-adre
noceptor agonist, 1 mg/kg) decreased (37%-49%) the synthesis of dopa.
Also the antagonist ARC 239 (alpha(2B/C) selective, 5-40 mg/kg) increa
sed the synthesis of dopa in cortex (39%-46%) and hippocampus (17%-85%
). In contrast, the antagonist BRL 44408 (alpha(2D) selective, 1-10 mg
/kg) did not increase the synthesis of dopa in cortex, and increased i
t modestly in hippocampus only. The agonist guanoxabenz (alpha(2B/C) s
elective, 0.03-3 mg/kg) decreased the synthesis of dopa in both brain
regions (20%-65%), whereas the agonist oxymetazoline (alpha(2D) select
ive, 0.1-3 mg/kg) failed to do so. These results indicated that the al
pha(2)-autoreceptors that modulate the synthesis of dopa/NA are probab
ly associated with the alpha(2B/C)-subtypes. In cortex and hippocampus
, clonidine decreased (35%-53%) the synthesis of 5-HTP but Org 3770 fa
iled to induce the opposite effect (except the 2 mg/kg dose in cortex)
. BRL 44408 markedly increased the synthesis of 5-HTP in cortex (113%-
148%) but not in hippocampus. Similarly, also ARC 239 increased the fo
rmation of 5-HTP in cortex (36%-48%) but not in hippocampus, where it
was decreased (30%-55%). Oxymetazolinedecreased the synthesis of 5-HTP
in hippocampus (28%-30%) but failed to do so in cortex. Guanoxabenz i
n the low dose range (0.03-0.3 mg/kg) did not decrease the synthesis o
f 5-HTP in any brain region. These results indicated that the alpha(2)
-heteroreceptors that modulate the synthesis of 5-HTP/5-HT may well be
different from the proposed alpha(2B/C)-autoreceptors modulating the
synthesis of dopa/NA. These alpha(2)-heteroreceptors appear to be asso
ciated with the alpha(2D)-subtype.